Fibromyalgia

Fibromyalgia severity is correlated to how long the condition takes to get diagnosed, a new study showed.

The rheumatology month in review for June 2024 addresses the critical role of psychological, socioeconomic, and lifestyle factors in the management of rheumatic diseases, particularly rheumatoid arthritis and fibromyalgia.

Shai Efrati, MD, explains how his research aims to address the root cause of fibromyalgia: damaged brain tissue.

Treatment involved repairing the brain tissue using HBOT, which led to significant symptom improvement.

A study presented at EULAR 2024 found fibromyalgia and worse pain, symptom severity, and depression scores were linked to a risk of low medication adherence.

A study presented at EULAR 2024 found a positive correlation between RA disease activity levels and mood disorders.

A study from EULAR details the ability of the FIRST self-questionnaire to identify fibromyalgia in patients with rheumatoid arthritis.

A recent study suggests fibromyalgia has little effect on polysomnographic indicators of obstructive sleep apnea-hypopnea syndrome.

At EULAR, Tonix Pharmaceuticals presented the phase 3 RESILIENT trial which met the primary endpoint of TNX-102 SL reducing daily pain intensity.

Findings highlight significant improvements in psychological constructs related to pain and quality of life following an 8-week intervention with hyperbaric oxygen therapy.

Exactly half of the sample had previously read or applied ≥ 1 Clinical Practice Guideline in the field of fibromyalgia.

The rheumatology month in review addresses opioid concerns and promotes holistic care in managing chronic conditions.

A significantly greater improvement in total FIQ scores was observed among patients with fibromyalgia receiving rTMS compared with placebo.

An analysis of more than 1800 adults with psoriatic arthritis found more than 20% of patients report widespread pain, with 10% meeting fibromyalgia criteria.

These findings can be used to enhance usability of the digital health app and improve outcomes and quality of life among patients with long COVID.

Pain relief and healthcare satisfaction were significantly increased in patients who were educated about their fibromyalgia and received care from a knowledgeable clinician who gave them information and guidance.

Treatment-resistant depression with intranasal esketamine was linked to improvements in major depressive disorder (MDD) symptoms and fibromyalgia pain in a 40-year-old female.

Cardiorespiratory fitness showed the strongest association with gait parameters for women with fibromyalgia.

Patients in the Mediterranean diet group reported improvements in most fibromyalgia measures, including anxiety, fatigue, and disability scores.

This month's review showcases the ongoing efforts to enhance patient care through innovative treatments and comprehensive management strategies.

Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.

Almost 50% of fibromyalgia patients use cannabis for symptom relief, according to new study. Experts suggest results underline need for clinician awareness, further research.

EULAR’s fibromyalgia guidelines provide comprehensive recommendations for managing active fibromyalgia to assist clinicians in making informed decisions. Test your knowledge with this quiz.

Without controlling for the severity of symptoms, patients with either fibromyalgia or RA performed worse when compared with controls in terms of cognitive domains including verbal memory, visual memory, and strategic planning.

Results offer important guidance for healthcare providers to develop tailored treatment strategies that align with the unique needs and preferences of individual patients.